Drugmaker Sanofi to raise over $11 billion via sale of Regeneron shares

PARIS (Reuters) - Sanofi will raise over $11 billion (8.93 billion pounds) from the sale of 21.6 million shares in its U.S. partner Regeneron , the French drugmaker said on Wednesday, adding it would use the proceeds for innovation and general growth.Earlier this week, Regeneron had said it would repurchase about $5 billion of its shares directly from Sanofi, without altering their over-a-decade-long partnership.Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around..